These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 16776624)

  • 1. Lack of association between alpha2B-adrenergic receptor polymorphism and risk of restenosis following coronary angioplasty and stent implantation--preliminary report.
    Manolis AS; Patsouras N; Ilias I; Constantakopoulos J; Pyriohou A; Lymperopoulos A; Spathas DH; Flordellis CS
    Clin Chem Lab Med; 2006; 44(7):807-12. PubMed ID: 16776624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insertion/deletion polymorphism in alpha2-adrenergic receptor gene is a genetic risk factor for sudden cardiac death.
    Laukkanen JA; Mäkikallio TH; Kauhanen J; Kurl S
    Am Heart J; 2009 Oct; 158(4):615-21. PubMed ID: 19781422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between the ACE genotype and coronary artery disease. Insights from studies on restenosis, vasomotion and thrombosis.
    Bauters C; Amouyel P
    Eur Heart J; 1998 Sep; 19 Suppl J():J24-9. PubMed ID: 9796837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An insertion/deletion polymorphism in the alpha2B-adrenergic receptor gene is a novel genetic risk factor for acute coronary events.
    Snapir A; Heinonen P; Tuomainen TP; Alhopuro P; Karvonen MK; Lakka TA; Nyyssönen K; Salonen R; Kauhanen J; Valkonen VP; Pesonen U; Koulu M; Scheinin M; Salonen JT
    J Am Coll Cardiol; 2001 May; 37(6):1516-22. PubMed ID: 11345359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ACE gene polymorphism and coronary restenosis.
    Bauters C; Amouyel P; Bertrand ME
    Semin Interv Cardiol; 1999 Sep; 4(3):145-9. PubMed ID: 10545620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized comparison of J&J Crown stent versus NIR stent after routine coronary angioplasty.
    Miketic S; Carlsson J; Tebbe U
    Am Heart J; 2001 Nov; 142(5):E8. PubMed ID: 11685183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 5A6A polymorphism in the promoter of the stromelysin-1 (MMP3) gene as a risk factor for restenosis.
    Humphries S; Bauters C; Meirhaeghe A; Luong L; Bertrand M; Amouyel P
    Eur Heart J; 2002 May; 23(9):721-5. PubMed ID: 11977998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of association between the cholesteryl ester transfer protein gene--TaqIB polymorphism and coronary restenosis following percutaneous transluminal coronary angioplasty and stenting: a pilot study.
    Kaestner S; Patsouras N; Spathas DH; Flordellis CS; Manolis AS
    Angiology; 2010 May; 61(4):338-43. PubMed ID: 19815603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group.
    Serruys PW; de Jaegere P; Kiemeneij F; Macaya C; Rutsch W; Heyndrickx G; Emanuelsson H; Marco J; Legrand V; Materne P
    N Engl J Med; 1994 Aug; 331(8):489-95. PubMed ID: 8041413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin-converting enzyme insertion/deletion polymorphism and risk of restenosis after directional coronary atherectomy followed by stent implantation.
    Canosi U; Angelica Merlini P; Bernardi F; Repetto A; Bramucci E; Ferrario M; Angoli L; Gnecchi M; Ferraresi P; Marchetti G; Tavazzi L; Ardissino D
    Thromb Haemost; 2004 Apr; 91(4):795-800. PubMed ID: 15045142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of distal/bifurcation left main restenosis after drug eluting stents implantation: single center experience.
    Rigatelli G; Cardaioli P; Dell'Avvocata F; Giordan M; Vassilev D; Fraccaro C; Roncon L; Faggian G
    Cardiovasc Revasc Med; 2014 Mar; 15(2):76-9. PubMed ID: 24560299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent in-stent restenosis is not associated with the angiotensin-converting enzyme D/I, angiotensinogen Thr174Met and Met235Thr, and the angiotensin-II receptor 1 A1166C polymorphism.
    Gross CM; Perrot A; Geier C; Posch MG; Hassfeld S; Kramer J; Schmidt S; Derer W; Dietz R; Ozcelik C
    J Invasive Cardiol; 2007 Jun; 19(6):261-4. PubMed ID: 17541127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomised trial of endoluminal reconstruction comparing the NIR stent and the Wallstent in angioplasty of long segment coronary disease: results of the RENEWAL Study.
    Nageh T; de Belder AJ; Thomas MR; Williams IL; Wainwright RJ
    Am Heart J; 2001 Jun; 141(6):971-6. PubMed ID: 11376312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of RAGE gene polymorphisms with in-stent restenosis in non-diabetic Korean population.
    Shim CY; Park S; Yoon SJ; Park HY; Kim HT; Oh B; Park C; Ko YG; Choi D; Jang Y; Chung N
    Cardiology; 2007; 107(4):261-8. PubMed ID: 16954682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The angiotensinogen gene 235T variant is associated with an increased risk of restenosis after percutaneous transluminal coronary angioplasty.
    Völzke H; Hertwig S; Rettig R; Motz W
    Clin Sci (Lond); 2000 Jul; 99(1):19-25. PubMed ID: 10887054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stents in total occlusion for restenosis prevention. The multicentre randomized STOP study. The Israeli Working Group for Interventional Cardiology.
    Lotan C; Rozenman Y; Hendler A; Turgeman Y; Ayzenberg O; Beyar R; Krakover R; Rosenfeld T; Gotsman MS
    Eur Heart J; 2000 Dec; 21(23):1960-6. PubMed ID: 11071802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency and time course of reocclusion and restenosis in coronary artery occlusions after balloon angioplasty versus Wiktor stent implantation: results from the Mayo-Japan Investigation for Chronic Total Occlusion (MAJIC) trial.
    Tamai H; Berger PB; Tsuchikane E; Suzuki T; Nishikawa H; Aizawa T; Fujii K; Nozaki Y; Kyo E; Kobayashi T; Reiber J; Van Weert AW;
    Am Heart J; 2004 Mar; 147(3):E9. PubMed ID: 14999211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stent placement to prevent restenosis after angioplasty in small coronary arteries.
    Doucet S; Schalij MJ; Vrolix MC; Hilton D; Chenu P; de Bruyne B; Udayachalerm W; Seth A; Bilodeau L; Reiber JH; Harel F; Lespérance J;
    Circulation; 2001 Oct; 104(17):2029-33. PubMed ID: 11673341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors predictive of cardiac events and restenosis after sirolimus-eluting stent implantation in small coronary arteries.
    Lee CW; Suh J; Lee SW; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
    Catheter Cardiovasc Interv; 2007 May; 69(6):821-5. PubMed ID: 17191211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association study of the I/D polymorphism and plasma angiotensin-converting enzyme (ACE) as risk factors for stent restenosis.
    Ribichini F; Ferrero V; Matullo G; Feola M; Vado A; Camilla T; Guarrera S; Carturan S; Vassanelli C; Uslenghi E; Piazza A
    Clin Sci (Lond); 2004 Oct; 107(4):381-9. PubMed ID: 15101817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.